John A. Lewicki

2015

In 2015, John A. Lewicki earned a total compensation of $1.4M as Executive Vice President, Research and Development at OncoMed Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$170,625
Option Awards$884,058
Salary$390,000
Total$1,444,683

Lewicki received $884.1K in option awards, accounting for 61% of the total pay in 2015.

Lewicki also received $170.6K in non-equity incentive plan and $390K in salary.

Rankings

In 2015, John A. Lewicki's compensation ranked 6,183rd out of 13,638 executives tracked by ExecPay. In other words, Lewicki earned more than 54.7% of executives.

ClassificationRankingPercentile
All
6,183
out of 13,638
55th
Division
Manufacturing
2,314
out of 5,190
55th
Major group
Chemicals And Allied Products
833
out of 1,854
55th
Industry group
Drugs
666
out of 1,528
56th
Industry
Pharmaceutical Preparations
520
out of 1,182
56th
Source: SEC filing on April 13, 2017.

Lewicki's colleagues

We found two more compensation records of executives who worked with John A. Lewicki at OncoMed Pharmaceuticals in 2015.

2015

Paul Hastings

OncoMed Pharmaceuticals

Chief Executive Officer

2015

Jakob Dupont

OncoMed Pharmaceuticals

Chief Medical Officer

In-depth

You may also like